HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches-Reference-Cited by-同舟云学术

HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches

Published:2010-08 Issue:2 Volume:62 Page:150-165
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Colombo Miriam,Corsi Fabio,Foschi Diego,Mazzantini Elisa,Mazzucchelli Serena,Morasso Carlo,Occhipinti Emanuela,Polito Laura,Prosperi Davide,Ronchi Silvia,Verderio Paolo

Publisher

Elsevier BV

Subject

Pharmacology

Reference173 articles.

1. Cancer statistics;Parker;CA Cancer J Clin,1996

2. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes;Veronesi;Lancet,1997

3. In vivo cancer targeting and imaging with semiconductor quantum dots;Batist;J Clin Oncol,2001

4. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer;Gao;Nat Biotechnol,2004

5. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer;Gradishar;J Clin Oncol,2005

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanobiosensing disease diagnostics for in vivo applications;Handbook of Nanomaterials, Volume 2;2024

2. Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy;Journal of Functional Biomaterials;2021-12-16

3. Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency;Experimental Cell Research;2021-08

4. A quantitative view on multivalent nanomedicine targeting;Advanced Drug Delivery Reviews;2021-02

5. Effects of variable domain orientation on anti‐HER2 single‐chain variable fragment antibody expressed in the Escherichia coli cytoplasm;Biotechnology Progress;2020-11-20